Cargando…
Pulmonary embolism after dexamethasone treatment for COVID-19: a case report
BACKGROUND: Although the RECOVERY trial showed that dexamethasone was efficacious for the treatment of coronavirus disease 2019 (COVID-19), its impact on the risk of pulmonary embolism (PE) and other serious procoagulant events was not assessed. CASE PRESENTATION: Here we report the case of a previo...
Autores principales: | Takahashi, Hidenori, Iwasaki, Yoshinobu, Watanabe, Takayasu, Ichinose, Naoki, Oda, Toshimi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938737/ https://www.ncbi.nlm.nih.gov/pubmed/35317729 http://dx.doi.org/10.1186/s12879-022-07228-2 |
Ejemplares similares
-
Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition
por: Takahashi, Hidenori, et al.
Publicado: (2020) -
Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors
por: Kurozumi, Atsumasa, et al.
Publicado: (2021) -
Listeria monocytogenes bacteremia one month after contact with raw venison: A case report
por: Takahashi, Hidenori, et al.
Publicado: (2022) -
Reply to Correspondence: Response to a case report: idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Fujii, Koki, et al.
Publicado: (2021) -
Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Fujii, Koki, et al.
Publicado: (2020)